A/Prof Jonathan Ramsay

MBChB, MSc, MD, FRANZCR, FRCP
Radiation Oncologist
Refer a patient

Biography

Associate Professor Jonathan Ramsay is a consultant radiation oncologist at Radiation Oncology Centres (ROC) Redland and Greenslopes, as well as Mater Centre South Brisbane.

In 2007 Dr Ramsay and two of his colleagues started Radiation Oncology Queensland, now ROC, and is still a consulting radiation oncologist at its centres.

Dr Ramsay completed his undergraduate research in the United Kingdom, achieving a medical degree at the University of Bristol and pursued postgraduate study at the University of London. Prior to beginning work in Australia, Dr Ramsay held a position for four years as clinical scientist with the University of Cambridge, and for two years as a research fellow with Harvard Medical School in the United States of America.

He continues to have an interest in clinical research having previously spent two years as a Fellow at Harvard Medical School and four years at Cambridge University Department of Clinical Oncology. In 2000 he was involved in the start up of Peplin Biotechnology which developed successful treatments for skin cancers. His clinical practice has been based in South Brisbane since 1994.

Dr Ramsay’s special interests include the treatment of breast and gynaecological cancers.

Special Interests

Dr Jonathan Ramsay accepts referrals for all cancer types, with a special clinical interest in:
  • Breast cancer
  • Gynaecological cancer

Icon Locations

Redland View centre

Visiting Locations

  • Mater Centre South Brisbane

Publications

  • Jones, Scott, Fitzgerald, Rhys, Owen, Rebecca and Ramsay, Jonathan (2015) Quantifying intra and inter-fractional motion in breast radiotherapy. Journal of Medical Radiation Sciences, 62 1: 40-46. doi:10.1002/jmrs.61

  • Burmeister, B. H., Fielding, D. I., Ramsay, J. R., Baumann, K. C., Dauth, M. and Walpole, E. T. (2005) A phase I study of moderate-dose radiation therapy and weekly gemcitabine in patients with locally advanced non-small cell lung cancer not suitable for radical chemoradiation therapy. Clinical Oncology, 17 5: 332-336. doi:10.1016/j.clon.2005.03.013

  • Leong, T, Whitty, J, Keilar, M, Mifsud, S, Ramsay, J, Birrell, G, Venter, D, Southey, M and McKay, M (2000) Mutation analysis of BRCA1 and BRCA2 cancer predisposition genes in radiation hypersensitive cancer patients. International Journal of Radiation Oncology Biology Physics, 48 4: 959-965. doi:10.1016/S0360-3016(00)00728-8

  • Ramsay, J., Birrell, G., Baumann, K., Bodero, A., Parsons, P. and Lavin, M. (1998) Radiosensitive melanoma cell line with mutation of the gene for ataxia telangiectasia. British Journal of Cancer, 77 1: 11-14. doi:10.1038/bjc.1998.2

  • Ramsay, J, Birrell, G and Lavin, M (1996) Breast cancer and radiotherapy in ataxia-telangiectasia heterozygote. Lancet, 347 9015: 1627-1627. doi:10.1016/S0140-6736(96)91114-9

  • Leonard, JH, Ramsay, JR, Kearsley, JH and Birrell, GW (1995) Radiation Sensitivity of Merkel Cell-Carcinoma Cell-Lines. International Journal of Radiation Oncology Biology Physics, 32 5: 1401-1407. doi:10.1016/0360-3016(94)00610-W

View all Doctors

Search